McKnight's Healthcare News
July 30, 2025
Polypharmacy, adverse drug events, the Beers Criteria, and pain management.
“Personalized prescribing in long-term care: Why it matters more than ever,” by Joel Diamond, CMO of AccessDx Laboratory, an Aranscia company, in McKnight’s Long-Term Care News, covers it all. Learn about hidden drug dangers, the application of pharmacogenomics as a tool in the LTC toolkit, and implementation and guidance for facilities.
Read the article here: https://www.mcknights.com/marketplace/marketplace-experts/personalized-prescribing-in-long-term-care-why-it-matters-more-than-ever/